UCB to sponsor trials at ‘giant site without borders’

By Flora Southey

- Last updated on GMT

(Image: Getty/oatawa)
(Image: Getty/oatawa)
Neurology and immunology trial participants will undertake "site-less" clinical trials under a partnership between Science 37 and drugmaker UCB.

According to the strategic collaboration, UCB-sponsored studies will use Science 37’s mobile research platform, the Network Oriented Research Assistant (NORA), to offer "site-less" trials.

The decentralized​ "Metasite" clinical trial model engages with subjects remotely to encourage greater retention of participants and reduce recruitment times.

“Science 37 is made up of one-part in-house technology team, the rest is a decentralized physician network who connect directly to patients 24/7/375 using our proprietary mobile platform,” ​explained Science 37 CEO Belinda Tan.

“We think of ourselves as a giant site without borders,” ​she added.

The partnership will also help UCB-sponsored studies reach remote or underserved communities, we were told.

The first ‘site-less’ UCB trial for Paediatric restless leg syndrome (RLS) is expected to begin this year.

Strategic collaborations

Science 37’s Metasite platform is attracting increased attention in the clinical development space. 

In December last year, Otsuka Pharmaceutical announced​ a strategic collaboration to explore the patient-centric trial method.

Additionally, in March 2018 Novartis​ – an early investor​ in Science 37 – committed​ to conducting up to ten clinical trials to scale up the "site-less" model.

Related news

Show more

Related products

show more

Using Define-XML to build more efficient studies

Using Define-XML to build more efficient studies

Content provided by Formedix | 14-Nov-2023 | White Paper

It is commonly thought that Define-XML is simply a dataset descriptor: a way to document what datasets look like, including the names and labels of datasets...

Overcoming rapid growth challenges with process liquid preparation

Overcoming rapid growth challenges with process liquid preparation

Content provided by Thermo Fisher Scientific - Process Liquid Preparation Services | 01-Nov-2023 | Case Study

A growing contract development manufacturing organization (CDMO) was challenged with the need to quickly expand their process liquid and buffer preparation...

Why should you use clinical trial technology?

Why should you use clinical trial technology?

Content provided by Formedix | 01-Nov-2023 | White Paper

New, innovative clinical trial technology is helping to revolutionize the research landscape. COVID-19 demonstrated that clinical trials can be run much...

Related suppliers

Follow us


View more